Precigen (PGEN) Provides Pipeline and Corporate Updates

Go back to Precigen (PGEN) Provides Pipeline and Corporate Updates

Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference

January 11, 2023 6:45 PM EST

  Company achieved significant progress for its clinical pipeline in 2022   Precigen to host R&D Day virtual event on January 24, 2023, at 4:30 PM ET to share safety and efficacy data from the Phase 1 dose escalation and expansion cohorts of PRGN-2012 AdenoVerse immunotherapy in recurrent respiratory papillomatosis (RRP)

GERMANTOWN, Md., Jan. 11, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq:... More